Club Compound
Member sign inStart consultation
Club Compound · Est. 2024

Evidence-informed peptide therapy, prescribed and compounded in the United States.

Physician-supervised protocols. Pharmacy-grade molecules. A category that has lived in the gray market for too long, brought into the open and held to the standards of the clinic.

Start your consultation Browse the formulary
LegitScript-certified 503A U.S. pharmacy HIPAA
01Compounded BPC-157, dispensed under prescription from a licensed U.S. pharmacy partner.
14
Peptides in formulary
42
State licenses
503A
Pharmacy class
Verified by
LegitScript
503A Compounding
HIPAA
Quest · LabCorp
U.S. Physicians
Cold-chain Shipping
The protocol

From intake to first dose in roughly two weeks — without the corner-cutting that defines this category online.

Every protocol is supervised by a U.S.-licensed physician and dispensed under prescription by a 503A compounding pharmacy in your state.

0130 min

Consultation

Intake with a U.S.-licensed physician — full medical history, goals, and contraindication screen.

02Week 1

Lab Work

Comprehensive panel drawn at a Quest or LabCorp near you. Results reviewed against age- and sex-adjusted reference ranges.

03Week 2

Physician Review

Your physician designs a protocol — peptide, dosing, titration, and check-in cadence specific to your labs.

04Week 2–3

Pharmacy Ship

Compounded by a 503A licensed U.S. pharmacy. Cold-chain shipped, with supplies, instructions, and a clinical follow-up scheduled.

Formulary

Eight molecules. One standard.

Each compound is third-party tested for purity and identity, prescribed by a licensed physician, and dispensed under your name. Click any peptide for protocol detail.

01Foundational

BPC-157

Body Protection Compound

Stabilizes growth-factor signaling at sites of soft-tissue injury; supports gut barrier integrity.

CategoryRecovery
Protocol8–12 weeks
RouteSubcutaneous
Requires consultation
02Signature

CJC-1295 / Ipamorelin

GHRH + Ghrelin Mimetic

Pulsed stimulation of endogenous growth-hormone release without disrupting natural feedback loops.

CategoryLongevity
Protocol3–6 months
RouteSubcutaneous, nightly
Requires consultation
03Signature

Tesamorelin

GHRH Analog

Selective reduction of visceral adipose tissue via sustained GHRH receptor activation.

CategoryBody Composition
Protocol12–24 weeks
RouteSubcutaneous, daily
Requires consultation
04Foundational

Semaglutide

GLP-1 Receptor Agonist

Slows gastric emptying and modulates appetite-regulatory pathways via GLP-1.

CategoryMetabolic
ProtocolTitration, 16+ weeks
RouteSubcutaneous, weekly
Requires consultation
05Premium

Tirzepatide

Dual GIP / GLP-1

Co-agonism of GIP and GLP-1 receptors for compounded metabolic effect.

CategoryMetabolic
ProtocolTitration, 20+ weeks
RouteSubcutaneous, weekly
Requires consultation
06Specialty

PT-141

Bremelanotide

Central melanocortin pathway activation — distinct mechanism from PDE5 inhibitors.

CategorySexual Health
ProtocolAs needed
RouteSubcutaneous
Requires consultation
07Premium

NAD+

Nicotinamide Adenine Dinucleotide

Replenishes a cofactor central to mitochondrial respiration and sirtuin signaling.

CategoryLongevity
ProtocolCycle protocol
RouteSubcutaneous or IV
Requires consultation
08Specialty

Thymosin Alpha-1

Tα1

Modulates T-cell maturation and innate-immune signaling for resilience protocols.

CategoryImmune
Protocol8–16 weeks
RouteSubcutaneous
Requires consultation
Showing 8 of 8 compoundsView full formulary
BPC-157 is a 15-amino-acid sequence isolated from a protective protein in the human gastric juice. In controlled studies, it stabilizes the local growth-factor environment at sites of soft-tissue and tendon injury — accelerating angiogenesis and collagen organization without the systemic load of an anabolic agent.

For Club Compound members, BPC-157 is most often prescribed during recovery from chronic tendinopathy, post-surgical rehabilitation, and gut-barrier protocols. It pairs cleanly with a clinical strength program rather than replacing one.

Standard protocol · adult male
8–12 weeks
PhaseDurationDoseFrequency
LoadingWk 1–2500 mcg2× daily
MaintenanceWk 3–10250 mcgDaily, AM
TaperWk 11–12250 mcg3× weekly
Washout≥ 4 weeksRe-evaluate
Final dose set by your prescribing physician based on weight, labs, and indication.
Read the full monograph
The line we draw

What separates compounded from research-grade.

Club Compound
Gray-market peptide vendors
Source
503A U.S. compounding pharmacy
Overseas "research" suppliers
Prescription
Required — written by a licensed MD/DO
None — sold for "research use only"
Identity & purity
Third-party tested, COA on file per lot
Self-reported, often no COA
Dosing guidance
Physician-titrated to your labs
User forums
Cold chain
Tracked, insulated cold-chain ship
Unrefrigerated postal service
Recourse
Pharmacy + provider on the hook
None
Become a member

The next two weeks decide what the next ten years feel like.

A consultation costs $95 and lasts thirty minutes. If we determine you're not a candidate for therapy, you don't pay for the visit.

Initial
$95
Physician consult — refundable
Membership
$49/mo
Includes follow-ups, lab review, dosing adjustments
Compounds
$120+
Per protocol, billed monthly · transparent pricing
Start your consultation Schedule a call
Frequently asked

Questions worth asking before you start.

Don't see yours? Email a physician directly.

Yes. Every protocol is prescribed by a U.S.-licensed physician and compounded by a 503A pharmacy registered in your state. Club Compound is LegitScript-certified and operates under HIPAA.
Gray-market vendors sell research chemicals labeled “not for human use.” Every milligram you receive from us is prescribed, third-party tested, and dispensed by a licensed compounding pharmacy under your physician's supervision.
Compounded peptide therapy is generally not covered by insurance. We publish transparent pricing and accept HSA / FSA where applicable. A typical protocol runs $180–$420/month inclusive of provider visits.
Baseline panels include CBC, CMP, lipid profile, HbA1c, IGF-1, total + free testosterone, estradiol, SHBG, and inflammatory markers. Follow-up labs are scheduled at 90 days.
Yes. Most protocols are designed in defined cycles with planned washout windows. Your physician will outline cycle length and re-evaluation cadence at the start.